John Grill AO

BSc BE(Hons) Hon DEng
Chair

John Grill AO

BSc BE(Hons) Hon DEng
Chair

John Grill was a founder and is currently the Chairman of Worley Ltd, Australia’s largest engineering and project management firm and a leading ASX-listed company operating in 51 countries. John has personal expertise in every aspect of project delivery in the resources and energy industries. In 2010, John was awarded an Honorary Doctorate from the University of Sydney in recognition of his contribution to the engineering profession. His influence on Australian society was acknowledged in the 2014 round of Australia Day Honours with the receipt of an Officer in the Order of Australia award. John has been Chairman of the Growth Centres Advisory Committee for the Department of Industry, Innovation and Science since 2015, a Director of Neuroscience Research Australia since 2010 and Chairman since 2016.

Dr Jennifer Alexander

MBBS, MHP, M Comm, FAICD FRACMA, FAFPHM (RACP)
Independent Director

Dr Jennifer Alexander

MBBS, MHP, M Comm, FAICD FRACMA, FAFPHM (RACP)
Independent Director

Dr Jennifer Alexander is a registered medical practitioner, with specialist qualifications in medical administration and public health medicine. She has extensive experience in the health industry in various CEO roles, and has also worked outside health in management education and training. She has held numerous public, private, government and not-for-profit Non-Executive appointments, which have included guiding organisations through restructuring, capital raising and listing on the ASX. Jennifer’s current portfolio includes appointment as an Independent Medical Advisor to the Medibank Private Board; Independent Member, Audit and Risk Committee, NSW State Emergency Service (SES) and non-executive Director roles with Doctors Health Services Pty Limited; Relationships Australia (NSW) and the UNSW Council.

Dr Julian Adler

MBBS (Hons), FRANZCR
Independent Director

Dr Julian Adler

MBBS (Hons), FRANZCR
Independent Director

Dr Julian Adler is a radiologist with subspecialty training in neuroradiology. He is CEO of Castlereagh Imaging and Illawarra Radiology Group, which are wholly-owned subsidiaries of Sonic Healthcare Ltd, providing radiology services across Sydney and the Illawarra. He represents Sonic in its joint venture radiology business in Melbourne, partnering with Epworth HealthCare, Victoria’s largest not-for-profit hospital operator and, in addition, he continues to practise as a clinical radiologist in Sydney. Prior to his involvement with Sonic, he was Co-founder of an international tele-radiology business that now operates in five countries and which was sold to a listed private equity company in late 2016.

Professor Jackie Curtis AM

MBBS (Hons), FRANZCP
Executive Director

Professor Jackie Curtis AM

MBBS (Hons), FRANZCP
Executive Director

Professor Jackie Curtis was appointed inaugural Executive Director in April 2020. She is a psychiatrist and was previously the Clinical Director of Youth Mental Health at the South Eastern Sydney Local Health District. Her research and clinical work over several decades has focused on early psychosis and youth mental health, including improving the cardiometabolic health of people living with serious mental disorders such as schizophrenia, with the aim of reducing health inequalities and increasing life expectancy. Jackie developed and implemented the internationally recognised Keeping the Body in Mind program, demonstrating that antipsychotic-induced weight gain can be prevented with lifestyle intervention, and is the co-founder and Co-Chair of the iphYs international working group advocating for improved physical health for youth experiencing psychosis. An invited committee member of the World Health Organisation working group for the international guidelines: management of physical health conditions in adults with severe mental disorders, Jackie is also a Conjoint Professor in the School of Psychiatry at UNSW Sydney. In 2023 she was the recipient of the prestigious Margaret Tobin Award from the Royal Australian and New Zealand College of Psychiatrists. In 2024, she was made a Member of the Order of Australia (AM) in the 2024 King’s Birthday Honours.

Peter Joseph AM

BComm, MBA
Black Dog Institute Nominee

Peter Joseph AM

BComm, MBA
Black Dog Institute Nominee

Peter has been in investment banking and business for over 40 years, much of that time as part of the Bankers Trust Australia group. He has been a Director and/or Chairman of many public and private companies including BT Australia, Dominion Mining, Bridge Oil, The GPT Group and Helitech Industries (Bell Helicopters). He has run a private family investment business through most of that time. As well as pursuing his own business interests, Peter continues his ‘second career’ of over 30 years in the not-for-profit sector. He was formerly Chairman, St Vincent’s Hospital (Sydney) Ltd and subsequently appointed inaugural Chairman of St Vincent’s and Mater Health Sydney. He was the inaugural Chairman of the Riverview College Council. He remains Chairman of the Black Dog Institute, The Ethics Centre and The Health-Science Alliance, UNSW Campus.

Dr Mark Nelson

BSc, MPhil, PhD
Independent Director

Dr Mark Nelson

BSc, MPhil, PhD
Independent Director

Dr Mark Nelson is Chairman, and Co-Founder of the Caledonia Investments Group. Prior to the establishment of Caledonia Investments in 1992, he was a Senior Investment Analyst and Institutional Advisor at Prudential-Bache Securities (Australia) Limited. Dr Nelson is also a Director of The Caledonia Foundation. He is currently Vice-President of the Board of Trustees of The Art Gallery of New South Wales, and a former Trustee of the Art Gallery of New South Wales Foundation. He is also the Deputy Chairman of Art Exhibitions Australia Limited, a Director of Kaldor Public Art Projects, and a Trustee of the Sydney Swans Foundation. He was formerly a Director of the Howard Florey Institute of Experimental Physiology and Medicine, and still serves as a Governor of the Florey Neuroscience Institutes, as well as being a Non-Executive Director of Telix Pharmaceuticals Ltd. Dr Nelson has considerable experience working in Australian and international investment and equity markets. He earned a PhD in Neuropharmacology from the University of Melbourne in 1986, an M. Phil from Cambridge University, and a BSc (Hons) degree from the University of Melbourne.

Professor Vlado Perkovic

MBBS, PhD, FRACP, FASN
UNSW Nominee

Professor Vlado Perkovic

MBBS, PhD, FRACP, FASN
UNSW Nominee

Prof Vlado Perkovic is Provost of UNSW Sydney and the senior deputy to the Vice-Chancellor, overseeing the development and implementation of UNSW’s strategy and supporting the University’s seven faculties to deliver exceptional research performance, education and social impact. He is a Scientia Professor at UNSW, a Professorial Fellow at The George Institute, and an active clinician in his role a Staff Specialist in Nephrology at the Royal North Shore Hospital. He was previously Dean of Medicine and Health at UNSW and prior to that Executive Director of The George Institute, Australia. He has published more than 350 papers and led international clinical trials focused on preventing the progression of kidney disease and its complications, and has been involved in developing Australian and global guidelines in kidney disease, cardiovascular risk assessment and blood pressure management. Vlado holds a PhD from the University of Melbourne and completed his undergraduate training at The Royal Melbourne Hospital. He is a Fellow of the Royal Australasian College of Physicians, the Australian Academy of Health and Medical Sciences, and the American Society of Nephrology. He serves on the editorial boards of several journals, including the New England Journal of Medicine.

Kristin Stubbins AM

B Com, BA
Independent Director

Kristin Stubbins AM

B Com, BA
Independent Director

Ms Stubbins was appointed a Member of the Order of Australia for services to finance, women and the community in 2023.  Her career in finance has spanned over 30 years working with some of Australia’s and the world’s leading companies. After many years as a Senior Partner at PwC, Kristin is now CEO and Founder of her own advisory business.  She was named as one of the Australian Financial Review’s 100 Women of Influence having been nominated in the innovation category.  In addition to her role on the Mindgardens Board, she is also currently a board member of Taronga Conservation Society and the Co-chair of Women for Change, an organisation that supports women in developing nations to achieve a tertiary education.

Tobi Wilson

SESLHD Nominee

Tobi Wilson

SESLHD Nominee

Tobi Wilson was appointed to the South Eastern Sydney Local Health District Chief Executive position in April 2019. Tobi brings a wealth of experience to the role, having held various executive positions, most recently spending two and a half years as General Manager of Prince of Wales Hospital and Sydney/Sydney Eye Hospitals. His extensive experience in executive and senior management roles also includes two years as Chief Operating Officer at the Royal Melbourne Hospital and Acting Chief Executive Officer, Southern Adelaide Local Health Network. In these roles, Tobi has demonstrated a proven ability to drive clinical change through redesign, including the delivery of several capital redevelopments. Tobi began his career as a physiotherapist, before completing a Masters of Health Science Management at the University of South Australia.

James MacNevin

NeuRA Nominee

James MacNevin

NeuRA Nominee

With more than 30 years financial services experience, focused on funds management, James MacNevin is the co-founder and Director of Hall Road Services, a firm providing specialist operations and technology services to Family Offices and Not-for-Profit organisations.

Prior to establishing Hall Road Services, James served as a senior managing director at State Street Global Advisors (SSGA), a US$4 trillion funds management firm, most recently as Head of Asia Pacific from 2018 to 2022.  Previous roles at SSGA included Chief Operating Officer, Asia Pacific and International Head of Operations and Technology, based in London.

In addition to business leadership, James has expertise across a broad range of areas including distribution, product development, operations and technology.  James is also a Director and Chair of Neuroscience Research Australia (NeuRA), an independent medical research institute and a Mindgardens Member organisation.

Dr Debra Graves OAM

MBBS MHA FRACMA, FAICD, FRCPA (Hon)
SESLHD Nominee

Dr Debra Graves OAM

MBBS MHA FRACMA, FAICD, FRCPA (Hon)
SESLHD Nominee

Dr Debra Graves is current the Chair of the South Eastern Sydney Local Health District Board and Chairman of the Queensland Public Health and Scientific Services Advisory Boad.

She was previously the Chief Executive Officer of The Royal College of Pathologists of Australasia, a position she has held for over 25 years. She holds Bachelor of Medicine and Bachelor of Surgery degrees from the University of Queensland and a Master in Health Administration from the University of New South Wales.  She is a Fellow of the Royal College of Medical Administrators; a Fellow of the Australian Institute of Company Directors; and an Honorary Fellow of the Royal College of Pathologists of Australasia. She is also an Examiner for The Royal Australasian College of Medical Administrators.

Debra has had experience as a CEO and Medical Director in both public and private hospitals. She was also previously the Chairman of Pathology Awareness Australia, and Director of the non-profit online consumer resource Pathology Tests Explained.

Professor Cheryl Jones

MBBS (Hons), PhD, FRACP, FAHMS
SESLHD Nominee

Professor Cheryl Jones

MBBS (Hons), PhD, FRACP, FAHMS
SESLHD Nominee

Professor Cheryl Jones was appointed Dean of Medicine and Health at the University of NSW in June 2024. She is a world authority on childhood infectious disease, an internationally recognised clinician scientist and a key opinion leader in research, research training, clinical practice, and health workforce education.

Prior to joining UNSW, Professor Jones held senior leadership positions at the University of Sydney and University of Melbourne, most recently as Head of School and Dean of Sydney Medical School. Her PhD was undertaken at Harvard Medical School on genetically engineered replication defective herpes simplex viruses. Her research on encephalitis and congenital infections has changed global policy and practice. In 2018 she was made Fellow of the Australian Academy of Health & Medical Sciences, where she is also a Director and Council Member. She has obtained more that $35 million in research funding and published more than 170 peer reviewed articles.

Professor Jones is a Senior Staff Specialist at the Children’s Hospital at Westmead. She was made a life member of the Australian Society for Infectious Diseases in 2022  She served as a Ministerial appointed member of the Australian Technical Advisory Group on Immunisation during the COVID-19 pandemic.

She has chaired or been a member of multiple boards, technical advisory groups, statutory authorities and professional societies including the Medical Council of NSW, the RACP/RCPA Joint Training Committee in Infectious Diseases and Microbiology, Medical Deans Australian and NZ and the funding agencies National Health and Medical Research Council and the Australian Research Council.